Uscom Ltd has released a press release.
Uscom Receives $492K R&D Cash Refund
Filed with ASX ·
6ix hasn’t read this filing yet.
In the deck
Story so far
Earlier from Uscom
- New Hypertension Study Recommends Uscom BP Plus Measures
- Uscom receives GSA listing to sell to US Government
- Uscom BP plus Central Blood Pressure Monitor Released
- BP Plus and Mount Everest Hypertension Study
- USCOM cost effective replacement for ICU Ultrasound
Later from Uscom
- International Value Investor Takes Strategic Stake in Uscom
- Share placement
- BP Plus for US eHealth study
- New US IP for Uscom SpiroSonic Devices
- New Uscom Measure of Heart Function
Follow Uscom into a list and get an email when it puts out news.
Follow Uscom